Announcing the novel class of GABA-A receptor selective positive allosteric modulator antidepressants.
作者信息
Fasipe Olumuyiwa John, Agede Olalekan Ayodele, Enikuomehin Adenike Christiana
机构信息
Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo City, Ondo State, Nigeria.
Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of Ilorin, Ilorin, Kwara State, Nigeria.
出版信息
Future Sci OA. 2020 Nov 12;7(2):FSO654. doi: 10.2144/fsoa-2020-0108.
Abstract
摘要
相似文献
1
Announcing the novel class of GABA-A receptor selective positive allosteric modulator antidepressants.宣布新型GABA-A受体选择性正变构调节剂抗抑郁药。
Future Sci OA. 2020 Nov 12;7(2):FSO654. doi: 10.2144/fsoa-2020-0108.
2
Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.祖拉诺酮——用于治疗精神障碍的合成神经甾体：叙述性综述
Front Psychiatry. 2023 Dec 5;14:1298359. doi: 10.3389/fpsyt.2023.1298359. eCollection 2023.
3
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants.产后抑郁症药物治疗的进展：对标准护理抗抑郁药和新型神经活性甾体抗抑郁药的结构化综述
Ther Adv Psychopharmacol. 2022 Jan 28;12:20451253211065859. doi: 10.1177/20451253211065859. eCollection 2022.
4
Development of neuroactive steroids for the treatment of postpartum depression.用于治疗产后抑郁症的神经活性甾体药物的研发。
J Neuroendocrinol. 2022 Feb;34(2):e13019. doi: 10.1111/jne.13019. Epub 2021 Aug 30.
5
Neuroactive steroids - new possibilities in the treatment of postpartum depression.神经活性甾体——产后抑郁症治疗的新可能性。
Ceska Slov Farm. 2022 Fall;71(4):142-150.
6
Exploring the clinical potentials of zuranolone in managing postpartum depression: A new therapeutic horizon.探讨 Zuranolone 在治疗产后抑郁症中的临床潜力：新的治疗前景。
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 8;132:110983. doi: 10.1016/j.pnpbp.2024.110983. Epub 2024 Feb 25.
7
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?静脉注射布雷沙诺龙治疗产后抑郁症：它是什么，效果如何，会被使用吗？
Ther Adv Psychopharmacol. 2020 Nov 9;10:2045125320968658. doi: 10.1177/2045125320968658. eCollection 2020.
8
Modification of behavioral effects of drugs in mice by neuroactive steroids.神经活性甾体对小鼠药物行为效应的修饰作用。
Psychopharmacology (Berl). 2000 Mar;148(4):336-43. doi: 10.1007/s002130050060.
9
The Emerging Role of Neurosteroids: Novel Drugs Brexanalone, Sepranolone, Zuranolone, and Ganaxolone in Mood and Neurological Disorders.神经甾体的新作用：新型药物布雷沙诺龙、塞普拉诺龙、祖拉诺龙和加奈索龙在情绪和神经疾病中的应用
Cureus. 2024 Jul 31;16(7):e65866. doi: 10.7759/cureus.65866. eCollection 2024 Jul.
10
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.加奈索酮（CCD 1042；3α-羟基-3β-甲基-5α-孕烷-20-酮）的抗惊厥特性表征，一种γ-氨基丁酸（A）受体的选择性、高亲和力类固醇调节剂。
J Pharmacol Exp Ther. 1997 Mar;280(3):1284-95.
引用本文的文献
1
Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression.神经递质的生物合成和代谢在焦虑和抑郁药物发现中的作用。
Curr Pharm Des. 2024;30(33):2587-2596. doi: 10.2174/0113816128309913240704095334.
2
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population.治疗儿童癫痫的新型药物疗法
J Clin Med. 2024 Jun 18;13(12):3567. doi: 10.3390/jcm13123567.
3
Phenols and GABA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae.酚类与γ-氨基丁酸受体：从结构、分子作用机制到神经精神后遗症
Front Pharmacol. 2024 Jan 18;15:1272534. doi: 10.3389/fphar.2024.1272534. eCollection 2024.
4
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.利用全基因组分析探讨抑郁症的发病机制、复发风险预测和共患精神障碍。
Nat Med. 2023 Jul;29(7):1832-1844. doi: 10.1038/s41591-023-02352-1. Epub 2023 Jul 18.
5
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.他汀类药物在抑郁症中的重新定位的药理学基础：机制研究综述。
Transl Psychiatry. 2023 Jul 12;13(1):253. doi: 10.1038/s41398-023-02533-z.
6
Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development.别孕烯醇酮介导的γ-氨基丁酸A受体敏感性在经前烦躁障碍发病机制中的作用：迈向转化医学和药物开发的精确靶点
Front Psychiatry. 2023 Mar 2;14:1140796. doi: 10.3389/fpsyt.2023.1140796. eCollection 2023.
7
Welcome to volume 8 of .欢迎来到第8卷。 （你提供的原文不完整，缺少具体的书名等信息，这是根据现有内容给出的翻译）
Future Sci OA. 2021 Dec 1;8(1):FSO767. doi: 10.2144/fsoa-2021-0124. eCollection 2022 Jan.
本文引用的文献
1
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.神经甾体作为新型抗抑郁药和抗焦虑药：γ-氨基丁酸A受体及其他。
Neurobiol Stress. 2019 Sep 27;11:100196. doi: 10.1016/j.ynstr.2019.100196. eCollection 2019 Nov.
2
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents.用于临床的新型抗抑郁药的出现：阿戈美拉汀的矛盾之处与其他新型药物
IBRO Rep. 2019 Jan 9;6:95-110. doi: 10.1016/j.ibror.2019.01.001. eCollection 2019 Jun.
3
Brexanolone: First Global Approval.布雷沙诺龙：全球首次获批。
Drugs. 2019 May;79(7):779-783. doi: 10.1007/s40265-019-01121-0.
4
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development.产后抑郁症的药物治疗：现有方法和新药研发。
CNS Drugs. 2019 Mar;33(3):265-282. doi: 10.1007/s40263-019-00605-7.
5
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems.新一代抗抑郁药：基于谷氨酸/GABA 神经递质系统的新型快速作用治疗情绪障碍药物研发管线的最新进展。
Drug Discov Today. 2019 Feb;24(2):606-615. doi: 10.1016/j.drudis.2018.11.007. Epub 2018 Nov 14.
6
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) Receptor.神经活性甾体。2. 3α-羟基-3β-甲基-21-(4-氰基-1H-吡唑-1'-基)-19-去甲-5β-孕甾-20-酮（SAGE-217）：一种临床新一代神经活性甾体γ-氨基丁酸受体的正变构调节剂。
J Med Chem. 2017 Sep 28;60(18):7810-7819. doi: 10.1021/acs.jmedchem.7b00846. Epub 2017 Aug 17.
7
Neurosteroids: endogenous role in the human brain and therapeutic potentials.神经甾体：在人类大脑中的内源性作用和治疗潜力。
Prog Brain Res. 2010;186:113-37. doi: 10.1016/B978-0-444-53630-3.00008-7.
8
The GABAergic deficit hypothesis of major depressive disorder.重性抑郁障碍的 GABA 能不足假说。
Mol Psychiatry. 2011 Apr;16(4):383-406. doi: 10.1038/mp.2010.120. Epub 2010 Nov 16.
9
Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy.甘氨酰胺在难治性癫痫儿童和青少年患者中的临床评估。
Epilepsia. 2007 Oct;48(10):1870-4. doi: 10.1111/j.1528-1167.2007.01182.x. Epub 2007 Jul 18.
10
Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice.对γ-氨基丁酸（GABA）受体具有正向调节作用的别孕烯醇酮类似物可保护小鼠免受6赫兹电刺激诱发的局灶性癫痫发作。
Epilepsia. 2004 Jul;45(7):864-7. doi: 10.1111/j.0013-9580.2004.04504.x.
Zotero 插件